|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Solana E, Martinez-Camblor P, Minguela A. Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD. Cells. 2024 Dec 13;13(24):2066. doi: 10.3390/cells13242066. PubMed PMID: 39768157; PubMed Central PMCID: PMC11674578.
AÑO: 2024; IF: 5.1
|
39768157
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.1
|
|
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723
|
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|
|
Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martinez-Sanchez MV, Campillo JA, Gomez JM, Pelaez A, Garcia E, Herranz M, Hernandez-Olivo M, Martinez-Alfaro E, Alcaraz A, Munoz A, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.
AÑO: 2021; IF: 7.759
|